Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivar Bleumer

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
BMJ Case Reports|March 19, 2022
Microcystic stromal tumour of testisMarije Hoogland, Ivar Bleumer, Albert Suurmeijer
The Urologic Clinics of North America|September 5, 2003
Tumor antigens and markers in renal cell carcinomaPeter Mulders, Ivar Bleumer, Egbert Oosterwijk
The Canadian Journal of Urology|May 5, 2006
The role of adjuvant therapy in non-metastatic RCCIvar Bleumer, Pieter H M de Mulder, Peter F A Mulders
European Urology|June 20, 2003
Immunotherapy for renal cell carcinomaIvar Bleumer, Egbert Oosterwijk, Pieter De Mulder, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 2, 2007
Preliminary analysis of patients with progressive renal cell carcinoma vaccinated with CA9-peptide-pulsed mature dendritic cellsIvar Bleumer, Dorien M Tiemessen, Jeannette C Oosterwijk-Wakka, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 20, 2002
Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 studyJeannette C Oosterwijk-Wakka, Dorien M Tiemessen, Ivar Bleumer, et al.
The Journal of Urology|November 25, 2003
Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international populationKen-Ryu Han, Ivar Bleumer, Allan J Pantuck, et al.
JAMA Network Open|June 30, 2026
Single-Use vs Reusable Catheters for Intermittent Catheterization in Patients With Urinary Retention: The COMPARE Randomized Clinical TrialFelice E E van Veen, Coen H H Christiaans, Sophie A Berendsen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|March 19, 2022
Microcystic stromal tumour of testisMarije Hoogland, Ivar Bleumer, Albert Suurmeijer
The Urologic Clinics of North America|September 5, 2003
Tumor antigens and markers in renal cell carcinomaPeter Mulders, Ivar Bleumer, Egbert Oosterwijk
The Canadian Journal of Urology|May 5, 2006
The role of adjuvant therapy in non-metastatic RCCIvar Bleumer, Pieter H M de Mulder, Peter F A Mulders
European Urology|June 20, 2003
Immunotherapy for renal cell carcinomaIvar Bleumer, Egbert Oosterwijk, Pieter De Mulder, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 2, 2007
Preliminary analysis of patients with progressive renal cell carcinoma vaccinated with CA9-peptide-pulsed mature dendritic cellsIvar Bleumer, Dorien M Tiemessen, Jeannette C Oosterwijk-Wakka, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 20, 2002
Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 studyJeannette C Oosterwijk-Wakka, Dorien M Tiemessen, Ivar Bleumer, et al.
The Journal of Urology|November 25, 2003
Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international populationKen-Ryu Han, Ivar Bleumer, Allan J Pantuck, et al.
JAMA Network Open|June 30, 2026
Single-Use vs Reusable Catheters for Intermittent Catheterization in Patients With Urinary Retention: The COMPARE Randomized Clinical TrialFelice E E van Veen, Coen H H Christiaans, Sophie A Berendsen, et al.
Pageof 1